Greylin Investment Mangement Inc Johnson & Johnson Transaction History

Greylin Investment Mangement Inc

$566 Million
Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 76,310 shares of JNJ stock, worth $11.8 Million. This represents 1.97% of its overall portfolio holdings.

Number of Shares

76,310

Previous 76,460 0.2%

Holding current value

$11.8 Million

Previous $12.1 Million 7.79%

% of portfolio

1.97%

Previous 2.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$144.38 - $157.78 $21,657 - $23,667	-150 Reduced 0.2%	76,310 $11.2 Million
Q1 2024 Apr 24, 2024	SELL	$155.22 - $162.74 $59,138 - $62,003	-381 Reduced 0.5%	76,460 $12.1 Million
Q4 2023 Jan 25, 2024	SELL	$145.6 - $158.88 $179,233 - $195,581	-1,231 Reduced 1.58%	76,841 $12 Million
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $167,275 - $187,391	-1,074 Reduced 1.36%	78,072 $12.2 Million
Q2 2023 Jul 10, 2023	SELL	$154.35 - $166.11 $198,802 - $213,949	-1,288 Reduced 1.6%	79,146 $13.1 Million
Q1 2023 Apr 07, 2023	SELL	$151.05 - $180.26 $24,772 - $29,562	-164 Reduced 0.2%	80,434 $12.5 Million
Q4 2022 Jan 25, 2023	SELL	$160.2 - $179.79 $317,997 - $356,883	-1,985 Reduced 2.4%	80,598 $0
Q3 2022 Oct 13, 2022	SELL	$161.33 - $179.52 $260,547 - $289,924	-1,615 Reduced 1.92%	82,583 $13.5 Million
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $299,546 - $331,283	-1,781 Reduced 2.07%	84,198 $14.9 Million
Q1 2022 May 20, 2022	SELL	$158.14 - $179.59 $42,539 - $48,309	-269 Reduced 0.31%	85,979 $15.2 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $36,175 - $40,138	-232 Reduced 0.27%	86,248 $14.8 Million
Q3 2021 Oct 13, 2021	SELL	$161.5 - $179.47 $8,236 - $9,152	-51 Reduced 0.06%	86,480 $14 Million
Q2 2021 Jul 14, 2021	SELL	$159.48 - $171.07 $40,188 - $43,109	-252 Reduced 0.29%	86,531 $14.3 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $70,871 - $78,932	-463 Reduced 0.53%	86,783 $14.3 Million
Q4 2020 Jan 14, 2021	SELL	$137.11 - $157.38 $14,533 - $16,682	-106 Reduced 0.12%	87,246 $13.7 Million
Q3 2020 Oct 13, 2020	SELL	$140.38 - $153.83 $203,551 - $223,053	-1,450 Reduced 1.63%	87,352 $13 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $982,433 - $1.19 Million	-7,627 Reduced 7.91%	88,802 $12.5 Million
Q1 2020 Apr 09, 2020	SELL	$111.14 - $153.99 $141,703 - $196,337	-1,275 Reduced 1.3%	96,429 $12.6 Million
Q4 2019 Jan 09, 2020	SELL	$127.5 - $146.44 $416,925 - $478,858	-3,270 Reduced 3.24%	97,704 $14.3 Million
Q3 2019 Oct 11, 2019	SELL	$126.95 - $142.14 $571,275 - $639,629	-4,500 Reduced 4.27%	100,974 $13.1 Million
Q2 2019 Aug 15, 2019	SELL	$131.15 - $144.24 $609,191 - $669,994	-4,645 Reduced 4.22%	105,474 $14.7 Million
Q1 2019 Apr 09, 2019	SELL	$125.72 - $139.79 $154,635 - $171,941	-1,230 Reduced 1.1%	110,119 $15.4 Million
Q4 2018 Jan 14, 2019	SELL	$122.84 - $147.84 $1.27 Million - $1.53 Million	-10,333 Reduced 8.49%	111,349 $14.4 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $497,262 - $584,379	-4,090 Reduced 3.25%	121,682 $16.8 Million
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $34,626 - $38,210	290 Added 0.23%	125,772 $15.3 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $47,538 - $56,293	-380 Reduced 0.3%	125,482 $16.1 Million
Q4 2017 Jan 16, 2018	SELL	$131.22 - $143.62 $216,513 - $236,973	-1,650 Reduced 1.29%	125,862 $17.6 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $16.5 Million - $17.3 Million	127,512	127,512 $16.6 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Account

Greylin Investment Mangement Inc Johnson & Johnson Transaction History